• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION VIGILANT X4 CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION VIGILANT X4 CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G247
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Staphylococcus Aureus (2058); Sepsis (2067); No Code Available (3191)
Event Date 02/01/2020
Event Type  Injury  
Manufacturer Narrative
Approximated based on the date the manufacturer became aware of the event.(b)(4).Device evaluated by mfr: the baseline testing completed on the device found no failing conditions.All testing completed on the device passed or was not applicable, therefore no problem was detected.
 
Event Description
It was reported that the patient experienced infection of the cardiac resynchronization therapy (crt-d) system.It was believed that this infection had developed from the patient's pneumonia, though the date of onset of the infection was unknown.Intravenous antibiotics were administered, and the entire system was explanted.It was planned to return the device to boston scientific; however, the leads were retained at the pathology department of the hospital.No additional adverse patient effects were reported.
 
Event Description
It was reported that the patient experienced infection of the cardiac resynchronization therapy (crt-d) system.It was believed that this infection had developed from the patient's pneumonia, though the date of onset of the infection was unknown.Intravenous antibiotics were administered, and the entire system was explanted.It was planned to return the device to boston scientific; however, the leads were retained at the pathology department of the hospital.No additional adverse patient effects were reported.Additional information received indicates that the patient presented with acute kidney injury (aki) and chronic obstructive pulmonary disease (copd).The patient also diagnosed with acute bronchitis, positive for influenza b, sepsis, hypoxic respiratory failure, mrsa bacteremia and left ventricular (lv) lead lead vegetation.No additional adverse patient effects were reported.
 
Manufacturer Narrative
B.3./d.7.: approximated based on the date the manufacturer became aware of the event.F.10.: code 3191 is for surgery.Device evaluated by mfr: this supplemental report is being filed to capture the pertinent information of a new code added to h6.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIGILANT X4 CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key9945944
MDR Text Key187200970
Report Number2124215-2020-06452
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526589287
UDI-Public00802526589287
Combination Product (y/n)N
PMA/PMN Number
P010012/S436
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 01/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/09/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date02/19/2021
Device Model NumberG247
Device Catalogue NumberG247
Device Lot Number209770
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/13/2020
Date Manufacturer Received10/12/2020
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age73 YR
-
-